D4381 Billing: Avoid These Common Claim Errors

Last updated September 3, 2026

Every day, dental practices invest time diagnosing periodontal disease, performing scaling and root planing, and educating patients about the importance of saving their teeth. Yet when it comes to the placement of locally delivered antimicrobial agents, all too often the decision to incorporate this valuable treatment is driven by reimbursement concerns rather than clinical need.

Many practices skip treatment because they assume insurance won’t pay and that patients will be upset when they receive a bill in the mail for the balance. Others provide the therapy but don’t report it correctly. The result?

• Patients miss an evidence-based adjunctive treatment.
• Practices absorb unnecessary costs.
• Thousands of dollars in legitimate production disappear every year.

The reality is simple: if you’re providing FDA-approved localized antimicrobial therapy, you deserve to report it correctly. Here’s how.

What Is CDT Code D4381?

D4381 — Localized delivery of antimicrobial agents via a controlled release vehicle into diseased crevicular tissue, per tooth

This code is used when an FDA-approved sustained or controlled-release antimicrobial agent is placed directly into a periodontal pocket.

Examples include:

• Arestin®
• PerioChip®
• Atridox®

Unlike irrigation, these medications slowly release antimicrobial agents over an extended period of time, maintaining therapeutic concentrations within the periodontal pocket where bacteria continue to thrive after conventional therapy.

Why D4381 Matters

SRP may remove bacterial plaque and calculus from the root surface, yet not every pocket heals post-treatment.

Many patients return six weeks later with:

• Persistent 5–7 mm pockets
• Bleeding on probing
• Active inflammation
• Localized recurrent disease

Rather than immediately progressing to surgery, many periodontists and general dentists use localized antimicrobials as an adjunctive therapy to reduce bacterial load in these isolated sites.

For the patient, it may mean:

• Saving a tooth
• Avoiding surgery
• Reducing inflammation
• Preserving bone
• Protecting long-term oral health

That’s a clinical victory, and reporting it correctly protects the practice financially.

When Should D4381 Be Reported?

Generally, D4381 is appropriate when:

• The patient has documented periodontal disease.
• Scaling and root planing has already been completed.
• Residual periodontal pockets remain.
• FDA-approved localized antimicrobial medication is placed.
• The medication is inserted into a periodontal pocket.

Most carriers expect:

• Re-evaluation after SRP
• Persistent bleeding
• Pocket depths generally 5 mm or greater
• Updated periodontal charting

Many payors reimburse only after conventional periodontal therapy has failed to fully resolve localized disease.

D4381 Is Reported Per Tooth

One of the most common billing errors is misunderstanding the reporting unit.

D4381 is reported per tooth, not per quadrant or per site.

Fees may vary depending upon:

• Number of treated sites
• Material cost
• Practice fee schedule

Always report the actual tooth numbers on the claim.

Example:

Documentation Can Make—or Break—the Claim

Insurance carriers are not simply paying for medication. They’re paying for documented medical necessity.

Your clinical record should include:

• Diagnosis of periodontitis
• Previous SRP dates
• Current periodontal charting
• Pocket depths
• Bleeding on probing
• Attachment loss
• Radiographic bone loss
• Tooth numbers treated
• Medication used (generic name preferred)
• Clinical rationale for placement

Instead of simply documenting “Placed Arestin” in the Remarks section (Box 35) of the claim form, attach a narrative and indicate the enclosures to stay within the 80-character limit.

Narrative: 6mm M site of #13, 5mm D and 7mm B site of #14, 6mm L site of #15 and 6mm L site of #30. The fee listed reflects material costs and number of sites treated. Minocycline HCL microspheres applied.

Remarks (Box 35): Enclosures – clinical notes, perio charting from 6/1/26 and 8/1/26, and x-rays.* (79 characters)

Common Reasons Claims Are Denied

Many denials have nothing to do with the procedure itself. Instead, they result from avoidable billing mistakes.

Examples include, but are not limited to:

• Reporting D4381 at the SRP appointment. Many payors require completion of SRP, a healing interval, and periodontal re-evaluation. Submitting D4381 on the same day as initial SRP may result in denial.
• Using non-FDA-approved products. The descriptor specifically requires FDA-approved localized antimicrobial agents. Custom mixtures or non-approved products should not be reported under D4381.
• Missing tooth numbers. Claims are frequently denied when treated teeth are not identified. Always list every treated tooth.
• Poor clinical documentation. Simply stating “localized delivery” is rarely sufficient. Show why the patient required additional therapy.

D4381 vs. D4921: Controlled-Release Antimicrobial or Gingival Irrigation?

Another frequent error is confusing D4381 with D4921. These procedures are fundamentally different.

If chlorhexidine or another medicinal solution is simply irrigated into periodontal pockets without a controlled-release delivery system, D4921—not D4381—may be the appropriate code.

Is D4381 Reimbursed?

Reimbursement varies by plan.

Some plans:

• Pay routinely
• Require documentation
• Require prior SRP
• Limit frequency
• Restrict the number of reimbursable teeth
• Consider it a “take back” from future periodontal surgery

Coverage is determined by each payor’s policies and the patient’s benefits—not by the CDT code itself. The key is to understand each carrier’s requirements and to document medical necessity clearly.

When claims are denied, documentation is your strongest appeal. Insurance companies cannot see inflammation. They cannot probe periodontal pockets. They only see what you document.

Want to make sure your periodontal claims are coded, documented, and billed correctly the first time? Schedule a free consult with eAssist to see how our dental billing team can help.

Disclaimer: Insurance administration and dental billing recommendations, as well as interpretations of the CDT codes, represent the opinions of our experts. For the latest CDT codes and official interpretations, contact the American Dental Association or visit ADA.org. You are responsible for your own use of the CDT Codes, insurance administration, and dental billing.